Subodh Verma: Tirzepatide Improves Multiple Cardiovascular Risk Pathways
Subodh Verma, Heart Surgeon-Scientist at Unity Health Toronto, Professor and Canada Research Chair, CV Surgery at Temerty Medicine, shared a post on X about a recent article he and his colleagues co-authored, published in JACC, adding:
“Delighted to share this new JACC analysis from SURMOUNT-1.
Over 72 weeks, we saw improvements across multiple pathways linked to cardiovascular risk – including inflammation, insulin resistance, adiposity and hepatic stress, endothelial dysfunction, and thrombosis.
At the 15-mg dose of Tirzepatide, placebo-adjusted changes included a 55% reduction in hsCRP, 30% reduction in IL-6, 39% reduction in HOMA-IR, 61% reduction in leptin, and 44% reduction in PAI-1, with adiponectin increasing by 48%.”
Title: Comprehensive Long-Term Changes in Cardiovascular Risk Biomarkers With Tirzepatide: A SURMOUNT-1 Post Hoc Analysis
Authors: Naveed Sattar, Bruno Linetzky, Giacomo Ruotolo, Subodh Verma, Harald Sourij, Hui Wang, Kadie Vanderman, Jonathan M. Wilson, Ryan M. Griffin, Adam Stefanski, Paul M. Ridker

Stay updated on all scientific advnaces with Hemostasis Today.
-
Nov 19, 2026, 22:24Erik Nelson: Low Iron Can Raise A1c without Changing Blood Sugar
-
Nov 19, 2026, 22:23Erwin Loh: Daily Iron Supplementation Reduces Iron-Deficiency Anaemia in Children and Adolescents
-
Nov 19, 2026, 22:22Afifah Sardar: Why Can a Simple Painkiller like Aspirin Make You Bleed More?
-
Nov 19, 2026, 22:16Jonathan Penm: Perioperative Anticoagulation Management and Antithrombotic Stewardship Across 31 Countries
-
Nov 19, 2026, 22:15Salomao V.: Innovation in Hemophilia A Is Also About How Patients Receive Their Treatment
-
Nov 19, 2026, 16:27263 PolyU Students and Staff Unite to Donate Blood – Hong Kong Red Cross Blood Transfusion Service
-
Nov 19, 2026, 16:16Billy Otieno: The Future of Blood Donation Lies Beyond Collection
-
Nov 19, 2026, 15:58Hema Goyal: Hematocon 2026 Bringing Together Knowledge, Innovation and Excellence in Hematology
-
Nov 19, 2026, 15:44Chukwuemeka Amarachi: Understanding Complex Blood Grouping Beyond Routine ABO And RhD Typing